Search

everythinglearnresearchcommunity

for

Search:↓

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Decorin, a protein, may help start hair growth and could be used to treat hair loss.

Inhibiting class I HDACs helps maintain hair growth ability in skin cells.

Green tea extract helps prevent cell death and supports cell survival in hair cells exposed to a chemotherapy drug.

Hair health depends on various factors and hair loss can significantly affect a person's well-being; understanding hair biology is key for creating effective hair care treatments.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive stomach cancer.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive forestomach cancer.

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

Hair follicle development is controlled by interactions between skin tissues and specific molecular signals.

Planarian regeneration begins with a specific gene activation caused by injury, essential for healing and tissue regrowth.

Epigenetic changes control how adult stem cells work and can lead to diseases like cancer if they go wrong.

Estrogen therapy can reduce skin aging but has cancer risks.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

Inactive hair follicle stem cells help prevent skin cancer.

Noggin overexpression delays eyelid opening by affecting cell death and skin cell development.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Minoxidil boosts hair growth by triggering growth factor release from specific stem cells.

Aging in hair follicle stem cells leads to hair graying, thinning, and loss.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Type I interferons play a key role in the development of various skin diseases.

Arctiin helps protect hair cells from damage and death caused by oxidative stress.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

DHT affects hair follicle cells by changing microRNA levels, leading to less cell growth and more cell death.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

XIST RNA helps regenerate hair follicles by targeting miR-424 and activating hedgehog signaling.